[{"address1": "930 Winter Street", "address2": "Suite M-500", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "617 443 2400", "website": "https://aerovatetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 51, "companyOfficers": [{"maxAge": 1, "name": "Mr. Timothy P. Noyes M.B.A.", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 936899, "exercisedValue": 0, "unexercisedValue": 10446414}, {"maxAge": 1, "name": "Mr. George A. Eldridge", "age": 60, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 658600, "exercisedValue": 0, "unexercisedValue": 1968391}, {"maxAge": 1, "name": "Mr. Timothy J. Pigot", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 584600, "exercisedValue": 0, "unexercisedValue": 595619}, {"maxAge": 1, "name": "Dr. Benjamin T. Dake Ph.D.", "age": 47, "title": "Founder, President, COO & Secretary", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 435500, "exercisedValue": 0, "unexercisedValue": 975487}, {"maxAge": 1, "name": "Dr. Marinus  Verwijs Ph.D.", "age": 47, "title": "Chief Technical Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 439875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 372333, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hunter  Gillies M.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 512742, "exercisedValue": 0, "unexercisedValue": 313002}, {"maxAge": 1, "name": "Ms. Donna  Dea", "title": "Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Fischer", "title": "Executive Vice President of Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen K. Yu", "title": "Senior Vice President of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1722470400, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.7, "open": 1.71, "dayLow": 1.635, "dayHigh": 1.74, "regularMarketPreviousClose": 1.7, "regularMarketOpen": 1.71, "regularMarketDayLow": 1.635, "regularMarketDayHigh": 1.74, "beta": 1.021, "forwardPE": -1.05625, "volume": 354350, "regularMarketVolume": 354350, "averageVolume": 1212709, "averageVolume10days": 376230, "averageDailyVolume10Day": 376230, "bid": 1.67, "ask": 1.7, "bidSize": 400, "askSize": 200, "marketCap": 48709688, "fiftyTwoWeekLow": 1.25, "fiftyTwoWeekHigh": 32.415, "fiftyDayAverage": 6.2041, "twoHundredDayAverage": 16.503, "currency": "USD", "enterpriseValue": -49873916, "floatShares": 10155802, "sharesOutstanding": 28822300, "sharesShort": 842564, "sharesShortPriorMonth": 2126640, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0292, "heldPercentInsiders": 0.00017999999, "heldPercentInstitutions": 1.08747, "shortRatio": 0.27, "shortPercentOfFloat": 0.0747, "impliedSharesOutstanding": 28992900, "bookValue": 3.258, "priceToBook": 0.5187232, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -82187000, "trailingEps": -3.03, "forwardEps": -1.6, "enterpriseToEbitda": 0.565, "52WeekChange": -0.8869565, "SandP52WeekChange": 0.19031036, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "AVTE", "underlyingSymbol": "AVTE", "shortName": "Aerovate Therapeutics, Inc.", "longName": "Aerovate Therapeutics, Inc.", "firstTradeDateEpochUtc": 1625059800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "cbf275de-3fc7-3baa-b402-2df34de7643f", "messageBoardId": "finmb_650355034", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.69, "targetHighPrice": 3.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.25, "targetMedianPrice": 2.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 4, "totalCash": 99334000, "totalCashPerShare": 3.448, "ebitda": -88285000, "totalDebt": 774000, "quickRatio": 6.401, "currentRatio": 6.653, "debtToEquity": 0.851, "returnOnAssets": -0.47785, "returnOnEquity": -0.80575997, "freeCashflow": -38999500, "operatingCashflow": -69027000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-11"}]